Gamma-hydroxybutyrate is a GABA(b) receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 261-265

  Madden, Theresa E ^a   Johnson, Steven W ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; BICUCULLINE; NCS 382; STRYCHNINE; TETRODOTOXIN; TETRYLAMMONIUM; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID B RECEPTOR; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CALCIUM CHANNEL; OXYBATE SODIUM; POTASSIUM CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; DOPAMINE RELEASE; MALE; MEMBRANE CURRENT; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM; VOLTAGE CLAMP; ANIMAL; CELL MEMBRANE POTENTIAL; DRUG EFFECT; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM CHANNELS; GABA MODULATORS; MALE; MEMBRANE POTENTIALS; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B; SODIUM OXYBATE; VENTRAL TEGMENTAL AREA;

EID: 0032219608     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. +-dependent uptake system for γ-hydroxybutyrate in membrane vesicles prepared from rat brain. J Neurochem 38:570-1575.
2. B receptor pharmacology. Annu Rev Pharmacol Toxicol 33:109-147.
3. Bozarth MA and Wise RA (1981) Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 28:551-555.
4. Cash CD (1994) Gamma-hydroxybutyrate: An overview of the pros and cons for its being a neurotransmitter and/or a useful therapeutic agent. Neurosci Biobehav Rev 18:291-304.
5. Da Prada M and Keller HH (1976) Baclofen and γ-hydroxybutyrate: Similar effects on cerebral dopamine neurons. Life Sci 19:1253-1264.
6. Di Chiara G and Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci (USA) 85:5274-5278.
7. B-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 348:491-497.
8. Feigenbaum JJ and Hoard SG (1997) Naloxone reverses the inhibitory effect of γ-hydroxybutyrate on central DA release in vivo in awake animals: A microdialysis study. Neurosci Lett 224:71-74.
9. Gallimberti L, Ferri M, Ferrara SD, Fadda F and Cessa GL (1992) γ-Hydroxybutyric acid in the treatment of alcohol dependence: A double-blind study. Alcohol Clinical Experimental Research 16:673-676.
10. Gallimberti L, Schifano F, Forza G, Miconi L and Ferrara SD (1994) Clinical efficacy of γ-hydroxybutyric acid in treatment of opiate withdrawal. Eur Arch Psychiat Clin Neurosci 244:113-114.
11. Galloway GP, Frederick SL, Staggers FE, Jr., Gonzales M, Stalcup SA and Smith DE (1997) γ-Hydroxybutyrate: An emerging drug of abuse that causes physical dependence. Addiction 92:89-96.
12. Grace AA and Onn S-P (1989) Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro. J Neurosci 9:3463-3481.
13. Harris NC, Webb C and Greenfield SA (1989) The effects of γ-hydroxybutyrate on the membrane properties of guinea-pig pars compacta neurons in the substantia nigra in vitro. Neurosci 31:363-370.
14. Hechler V, Bourguignon JJ, Wermuth CG, Mandel P and Maitre M (1985) γ-Hydroxybutyrate uptake by rat brain striatal slices. Neurochemical Res 10:387-396.
15. Hechler V, Gobaille S, Bourguignon J-J and Maitre M (1991) Extracellular events induced by γ-hydroxybutyrate in striatum: A microdialysis study. J Neurochem 56:938-944.
16. Hechler V, Gobaille S and Maitre M (1992) Selective distribution pattern of γ-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res 572:345-348.
17. B binding that is blocked by valproate and ethosuximide. J Pharmacol Exp Ther 281:753-760.
18. B receptor antagonist, in the lethargic mouse, γ-hydroxybutyrate, and pentylenetetrazole models. J Pharmacol Exp Ther 274:1399-1403.
19. Howard SG and Feigenbaum JJ (1996) Effect of γ-hydroxybutyrate on central dopamine release in vivo. Biochem Pharmacol 53:103-110.
20. B receptor in cultured cerebellar granule cells. J Neurochem 65:75-83.
21. B synaptic potential in rat dopamine neurons. J Neurosci 12:2000-2006.
22. Johnson SW and North RA (1992) Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol (Lond) 450:455-468.
23. + currents. Neurosci Lett 231:13-16.
24. Macdonald RL and Barker JL (1979) Anticonvulsant and anesthetic barbiturates: Different postsynaptic actions in cultured mammalian neurons. Neurol 29:432-447.
25. B receptors in the rat midbrain slice (Abstract). Soc Neurosci 22:1293.
26. Maitre M, Hechjler V, Vayer P, Gobaille S, Cash CD, Schmitt M and Bourguignon J-J (1990) A specific γ-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J Pharmacol Exp Ther 255:657-663.
27. Maitre M (1997) The γ-hydroxybutyrate signalling system in brain: Organization and functional implications. Prog Neurobiol 51:337-361.
28. Marwick C (1997) Coma-inducing drug GHB may be reclassified. J Am Med Assoc 277:1505-1506.
29. Nissbrandt H, Elverfors A and Engberg G (1994) Pharmacologically induced cessation of burst activity in nigral dopamine neurons: Significance for the terminal dopamine efflux. Synapse 17:217-224.
30. B-receptor antagonist, CGP 35348, antagonises γ-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice. J Neural Transm [GenSect] 103: 1255-1263.
31. Shen K-Z, Cox BA and Johnson SW (1997) L-Arginine potentiates GABA-mediated synaptic transmission by a nitric oxide-independent mechanism in rat dopamine neurons. Neurosci 79:649-658.
32. Snead OC, III (1977) Gamma hydroxybutyrate. Life Sci 20:1935-1943.
33. B) receptor in rat brain. Biochem Pharmacol 52:1235-1243.
34. Vayer P, Mandel P and Maitre M (1985) Conversion of γ-hydroxybutyrate to γ-aminobutyrate in vitro. J Neurochem 45:810-814.
35. Vayer P, Mandel P and Maitre M (1987) Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci 41:1547-1557.
36. Vayer P and Maitre M (1988) Regional differences in depolarization-induced release of γ-hydroxybutyrate from rat brain slices. Neurosci Lett 87:99-103.
37. Walters JR, Roth RH and Aghajanian GK (1973) Dopaminergic neurons: Similar biochemical and histochemical effects of γ-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J Pharmacol Exp Ther 186:630-639.
38. Walters JR and Roth RH (1972) Effect of γ-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum. Biochem Pharmacol 21:2111-2121.
39. B receptor-mediated hyperpolarization. Neurosci 66:133-141.
40. B receptors. Eur J Pharmacol 212:291-294.